By: Loren Michel, MD Date: October 25, 2023 At the recent ESMO conference, Dr. Loren Michel presented the results of…
Browsing: Head and Neck
Oropharyngeal Cancer, Hypopharyngeal Cancer, Laryngeal Cancer, Lip and Oral Cavity Cancer, Nasopharyngeal Cancer, Paranasai Sinus and Nasal Cavity Cancer, Salivary Gland Cancer, Squamous Cell Neck Cancer, Soft Tissue Sarcoma, Thyroid Cancer, News and Information
Shirin Attarian, MD addresses the escalating incidence of head and neck cancer and highlights that most cases, particularly oropharyngeal cancers,…
Presented By: Shirin Attarian, MD Date Aug 12, 2023 In the realm of oncology, Head and Neck Cancer stands as…
When discussing the myriad of cancers that affect humans, head and neck cancers, though slightly less talked about, remain a…
In the ever-evolving landscape of medical science, melanoma and Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)…
Dr. Kevin Harrington, Phd of the Royal Marsden Hospital, The Institute of Cancer Research, London, is the author of this…
Ann M. Gillenwater, MD – MD Anderson, Department of Head and Neck Surgery, Division of Surgery presents the First Safety…
Ari Rosenberg, MD – University of Chicago The DEPEND trial investigated the use of neoadjuvant nivolumab, paclitaxel, and carboplatin followed…
Glenn Hanna, MD – Dana-Farber The combination of BCA101 and pembrolizumab as first-line therapy in patients with recurrent, metastatic head…
Head and neck cancer, collectively termed Head and Neck Cancer (HNC), is a group of biologically similar cancers that start…
Dr. Jessica Geiger from Cleveland Clinic presented an abstract at ASCO 2023 highlighting the potential of Enfortumab vedotin as a…
Join us in an insightful interview with renowned oncologist Dr. Emrullah Yilmaz, MD, PhD, as he discusses the potential of…
Squamous Cell Cancer, also known as squamous cell carcinoma (SCC), is an uncontrolled growth of abnormal cells arising in the…
iFrame is not supported! Molecule RRx-001 Receives Fast Track Designation From the FDA – EpicentRx By Tony Reid, MD, PhD,…
Molecule, RRx-001, has received fast track designation from the FDA. RRx-001 is a designer molecule with direct anti-inflammatory activity and…
Head and Neck Cancer: Discussion on Endocrine Oncology Research Innovations – Moffitt Moffitt Cancer CenterHost: Caitlin McMullen, MD, Member,…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist, specialized in lung, head and neck, Professor, Department of Medicine, UC…
In this video series Dr. Kathryn Gold, Medical Oncologist specializing in lung, head and neck cancers, Professor with the Department…
El Dr. Jared Weiss se une a nosotros para analizar la importancia de las pruebas y el diagnóstico temprano en…
El Dr. Jared Weiss se une a nosotros para analizar la importancia de las pruebas y el diagnóstico temprano en…
El Dr. Jared Weiss se une a nosotros para analizar la importancia de las pruebas y el diagnóstico temprano en…
Dr. Jared Weiss joins us to discuss the importance of testing and early diagnosis in cancer care, with a concentration…
Dr. Jared Weiss joins us to discuss the importance of testing and early diagnosis in cancer care, with a concentration…
Dr. Jared Weiss joins us to discuss the importance of testing and early diagnosis in cancer care, with a concentration…
iFrame is not supported! Genomic-Adjusted Radiation Dose Explained [2022] What Is Genomic-Adjusted Radiation Dose (GARD)? Genomic-Adjusted Radiation Dose (GARD)…
Genomic-Adjusted Radiation Dose Explained [2022] What Is Genomic-Adjusted Radiation Dose (GARD)? Genomic-Adjusted Radiation Dose (GARD) is a mathematical formalism…
OncTalk 2021, a live-online, patient education event featured top oncologists discussing Early Stage and Advanced Non-Small Cell Lung Cancer. This…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Jared…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
We are pleased to share updates to the GRACE Patient Education Program on HPV Advances. In this video, Dr. Wendell…
Umamaheswar Duvvuri, MD, Ph.D., FACS, Professor, Department of Otolaryngology at UPMC and the VA Pittsburg Health System. In this video,…
Umamaheswar Duvvuri, MD, Ph.D., FACS, Professor, Department of Otolaryngology at UPMC and the VA Pittsburg Health System. In this video,…
Philippe Spiess, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about the ASCO 2021 Abstract – Clinically…
Eyal Talor, Ph.D., Chief Scientific Officer, Cel-Sci speaks about CEL-SCI’S Multikine® Immunotherapy Produces significant 14.1% 5-Year Survival Benefits (62.7% VS…
Philippe Spiess, MD from H. Lee Moffitt Cancer Center & Research Institute speaks about the ASCO 2021 Abstract – Clinically…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…
We are pleased to present this newest video series of updates from ASCO and ESMO 2020, with discussions on updates…